Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Australia passes off-patent drugs price cut bill

This article was originally published in Scrip

Executive Summary

Australia's parliament passed its medicines bill this week, bringing price disclosures and weighted average price cuts of 23% for off-patent and generic medicines for the state funded Pharmaceutical Benefits Scheme (PBS). The passage was welcomed by the industry association Medicines Australia which had wanted the bill to be passed this month as price disclosures are expected to start from 1 December (, 3 November 2010).






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts